| 41 | Frrs1l 유전자 녹아웃 자폐 스펙트럼 장애 동물모델 및 이의 용도 한진희; 최정균; 김무준 |
| 42 | Fusion Protein Capable of Binding VEGF-A and TNF-alpha 고규영; 정기훈; 고영준; 이균민; 김선창, 2015-01-06 |
| 43 | Genetically engineered mouse model for autism spectrum disorder having deletion of Shank2 gene and use thereof 김은준; 강봉균; 이민구, 2016-01-12 |
| 44 | Glycosyltransferase derived from Dolwoe and use thereof Kim, Sun Chang; Choi, Giltsu; Jung, Suk Chae; Kim, Woohyun; Lim, Soohwan; Im, Wan-Taek, 2018-07-20 |
| 45 | Induced pluripotent stem cell model for cardiofaciocutaneous syndrome and uses thereof Han, Yong-Mahn; Han, Kyu-Min, 2019-01-08 |
| 46 | Induced pluripotent stem cell model for Fabry disease and use thereof Han, Yong-Mahn; Park, Sang-Wook, 2019-05-14 |
| 47 | Inhibition of apoptosis by the expression of antisense RNA of caspase-3 이균민, 2005-09-13 |
| 48 | Inhibition of apoptosis by the expression of antisenseRNA of caspase-3 이균민; 김노수 |
| 49 | LDL-LIKE CATIONIC NANOPARTICLES FOR DELIVERYING NUCLEIC ACID GENE, METHOD FOR PREPARING THEREOF AND METHOD FOR DELIVERYING NUCLEIC ACID GENE USING THE SAME Park, Tae Gwan; KIM, Hyun-Ryoung, 2018-06-27 |
| 50 | LDL-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same Park, Tae Gwan; Kim, Hyun-ryoung; Kim, In-kyoung |
| 51 | LIN28A 메틸화 억제제를 포함하는 줄기세포 전능화 조절용 조성물 및 LIN28A 메틸화 억제제의 스크리닝 방법 이대엽; 김승균; 이호석, 2014-07-24 |
| 52 | MASS SPECTROMETRIC METHODS FOR SEQUENCING NUCLEIC ACIDS Kang, Chang Won; O'DONNELL, Maryanne J.; Kwon, Young Soo; Kim, Young Tae; KOSTER, Hubert; LITTLE, Daniel, P.; XIANG, Guobing; et al, 2003-11-26 |
| 53 | Mass spectrometric methods for sequencing nucleic acids 강창원, 2001-07-31 |
| 54 | Mass Spectrometric Methods for Sequencing Nucleic Acids 강창원, 2002-01-25 |
| 55 | Mass spectrometric methods for sequencing nucleic acids 강창원, 2004-01-08 |
| 56 | Mass spectrometric methods for sequencing nucleic acids 강창원, 2003-12-15 |
| 57 | Mass Spectrometric Methods for Sequencing Nucleic Acids 강창원; 권영수; 김영태; 쾨스터후베르트; 리틀다니엘피; 지앙구오빙; 러프데이비드엠; et al, 2002-07-19 |
| 58 | MERTK 억제제를 유효성분으로 함유하는 뇌전증의 예방 또는 치료용 약학적 조성물 정원석; 박정주 |
| 59 | MESOPOROUS SILICA NANOPARTICLE COMPOSITE FOR BIOMEDICAL TREATMENT, METHOD OF PRODUCING THE SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME Kang, Suk-Jo; Chun, Dong Min; Lee, Seung Hoon; Kang, Dong Wan; Kim, Jae Yun; Choi, Seung Woo |
| 60 | Method and kit for analyzing protein-protein interaction using nanocluster formation 허원도; 김선창; 이상규, 2017-10-10 |
| 61 | Method for Detecting Molecular Interaction 김태국, 2018-09-30 |
| 62 | Method for forming a reversible protein nanocluster using light in a cell 허원도; 이상규; 박혜림, 2017-07-18 |
| 63 | Method for Improving a Strain Based on In-Silico Analysis Lee, Sang Yup; Kim, Tae Yong; Lee, Daeyoup; Lee, Sang Jun |
| 64 | Method for manufacturing xylitol with high-yield and high-productivity 김정회, 2010-06-29 |
| 65 | Method for mass production of antimicrobial peptide 김선창, 2001-02-06 |
| 66 | METHOD FOR MASS PRODUCTION OF ANTIMICROBIAL PEPTIDE 김선창; 이재현 |
| 67 | Method for Preparing Biocompatible Scaffoldsand Scaffold Pre 박태관, 2002-09-09 |
| 68 | Method for preparing endocrine aggregate of insulin-producing beta cells from human pluripotent stem cells Han, Yong-Mahn; Kim, Young-jin; Kim, Hail, 2018-06-05 |
| 69 | METHOD FOR PREPARING RECOMBINANT GLYCOPROTEINS WITH HIGH SIALIC ACID CONTENT 김정회; 손영덕; 황진영; 정연태, 2016-07-13 |
| 70 | METHOD FOR PREPARING RECOMBINANT GLYCOPROTEINS WITH HIGH SIALIC ACID CONTENT Kim, Jung Hoe; Son, Young Dok; Hwang, Jin Young; Jeong, Yeon Tae, 2015-01-27 |
| 71 | METHOD OF INDUCING DIFFERENTIATION OF EMBRYONIC STEM CELLS INTO HEMANGIOBLAST Han, Yong Mahn; Park, Sang-Wook; Lee, Eun-Young, 2013-08-13 |
| 72 | Methods for detecting molecular interactions Kim, Tae Kook; Lee, Seung Goo; Lee, Sang Kyu; Lee, Kyoung Hu; Ha, Jae-Seok, 2015-10-20 |
| 73 | Methods for treating Parkinson`s disease Kim, Daesoo; Kim, Jeongjin; Kim, Youngsoo; Jeong, Minju |
| 74 | Microorganism for production of putrescine and methods for production of putrescine using the same 김학성; 최향; 경현호; 정희경; 최정민; 이중재; 서효덕 |
| 75 | Microorganism having minimal genome and method of producing the same Kim, Sun Chang; Cho, Byung-Kwan; Choe, Donghui; Sung, Bong Hyun; Lee, Jun Hyoung |
| 76 | Microorganisms with enhanced carbon monoxide availability and use thereof Cho, Byung-Kwan; Song, Yoseb; Shin, Jongoh; Jin, Sangrak; Kang, Seulgi |
| 77 | Modified ornithine decarboxylase protein and a use thereof Choi, Hyang; Jung, Hee Kyoung; Kim, Hak-Sung; Kyeong, Hyun Ho; Choi, Jung Min; Lee, Joong Jae; Seo, Hyo Deok, 2018-12-25 |
| 78 | MOUSE MODELS WITH ENHANCED ESSENTIAL TREMOR AND PREPARATION METHOD THEREOF 김대수, 2012-09-07 |
| 79 | MOUSE MODELS WITH ENHANCED ESSENTIAL TREMOR AND PREPARATION METHOD THEREOF 김대수; 박혜연; 장기영; 박영균, 2013-01-23 |
| 80 | MOUSE MODELS WITH ENHANCED ESSENTIAL TREMOR AND PREPARATION METHOD THEREOF KIM, DAESOO; CHANG, KI YOUNG; PARK, HYEYEON; Park, Young-Gyun |
| 81 | mRNA의 세포내 안정성과 생합성을 향상시키는 래리엇 캡 구조의 RNA, 및 이의 용도 김윤기; 장지윤 |
| 82 | MULTIMERIC siRNA AND PREPARATION METHOD THEREFOR Park, Tae Gwan; 목혜정; 이수현 |
| 83 | NOVEL ANTICANCER AGENTS COMPRISING PEPTIDES WITH CANCER-SPECIFIC TOXICITY Kim, Sun-Chang; Jang, Su A; Kim, Da Jung; Sung, Bong Hyun; Lim, Ki Jeong; Shin, Ju Ri; Lee, Young Woong, 2015-06-30 |
| 84 | Novel biological polymer Lebeault, J. M.; Kim, Jung-Hoe; Choi, Joon-Ho |
| 85 | NOVEL MUTANT ORNITHINE DECARBOXYLASE PROTEIN AND USE THEREOF 김학성; 최향; 경현호; 정희경; 최정민; 이중재; 서효덕, 2017-11-10 |
| 86 | Novel peptide having biological activity 김선창 |
| 87 | NOVEL PEPTIDES HAVING BIOLOGICAL ACTIVITY 김선창, 2007-11-13 |
| 88 | Novel pharmaceutical composition for treatment of dystonia Kim, Daesoo; Kim, Jung Eun |
| 89 | Novel UDP-glycosyltransferase derived from ginseng and use thereof 김선창; 최길주; 정석채; 임완택; 김우현; 이연, 2018-07-21 |
| 90 | NOVEL USE OF ANTIMICROBIAL PEPTIDES IN REGENERATION OF SKIN CELLS Kim, Sun-Chang; Kim, Da-Jung; Jang, Su-A; Sung, Bong Hyun; Lim, Ki-Jung; Shin, Ju-Ri; Lee, Young Woong, 2017-04-12 |
| 91 | Peptides having biological activity 김선창, 2003-03-11 |
| 92 | PHARMACEUTICAL COMPOSITION FOR SUPPRESSING APPETITE, CONTAINING N2-(M-TRIFLUOROBENZYL), N6-(P-NITROBENZYL)PURINE (TNP) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT Kim, Seyun; Kim, Min Seon; Kang, Gilmyoung |
| 93 | PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING RNA OLIGONUCLEOTIDE 최병석; 강석조; 이장현; 민지연; 전동민; 성시은 |
| 94 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; LEE, Janghyun; MIN, Ji Youn; CHUN, Dongmin; SUNG, Si-Eun |
| 95 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| 96 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| 97 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| 98 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| 99 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER COMPRISING RNA Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
| 100 | Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide Choi, Byong-Seok; Kang, Suk-Jo; Lee, Janghyun; Min, Ji Youn; Chun, Dongmin; Sung, Si-Eun |
